Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$481.71 USD
+5.56 (1.17%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $481.72 +0.01 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC11/4/24 |
---|---|
Current Quarter | 4.11 |
EPS Last Quarter | -12.83 |
Last EPS Surprise | -11.57% |
ABR | 1.93 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.05 |
Next Year | 18.04 |
EPS (TTM) | 0.21 |
P/E (F1) | 10,389.82 |
% EPS Growth Estimates | VRTX | IND | S&P |
---|---|---|---|
Current Qtr (09/2024) | 0.74 | 152.07 | 20.57 |
Next Qtr (12/2024) | -2.38 | 117.29 | 22.45 |
Current Year (12/2024) | -99.67 | 17.40 | 15.67 |
Next Year (12/2025) | 35,980.00 | 10.10 | 11.34 |
Past 5 Years | 38.20 | 4.00 | 8.10 |
Next 5 Years | 12.50 | 21.20 | NA |
PE | 10,389.82 | -7.70 | 23.54 |
PEG Ratio | 831.19 | -0.36 | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.68B | 2.73B | 10.74B | 11.83B |
# of Estimates | 11 | 11 | 12 | 11 |
High Estimate | 2.73B | 2.81B | 10.87B | 13.73B |
Low Estimate | 2.64B | 2.65B | 10.65B | 11.14B |
Year ago Sales | 2.48B | 2.52B | 9.87B | 10.74B |
Year over Year Growth Est. | 7.83% | 8.39% | 8.84% | 10.12% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.11 | 4.10 | 0.05 | 18.04 |
# of Estimates | 12 | 10 | 11 | 11 |
Most Recent Consensus | 3.91 | 4.23 | 0.10 | 17.44 |
High Estimate | 4.90 | 4.81 | 0.64 | 21.69 |
Low Estimate | 3.80 | 3.48 | -0.32 | 15.03 |
Year ago EPS | 4.08 | 4.20 | 15.23 | 0.05 |
Year over Year Growth Est. | 0.74% | -2.38% | -99.67% | 35,991.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.11 | 4.10 | 0.05 | 18.04 |
7 Days Ago | 4.11 | 4.10 | 0.05 | 18.04 |
30 Days Ago | 4.11 | 4.10 | 0.05 | 18.03 |
60 Days Ago | 4.11 | 4.10 | 1.58 | 18.04 |
90 Days Ago | 4.00 | 3.99 | 15.82 | 17.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 4.11 | 4.10 | 0.05 | 17.44 |
Zacks Consensus Estimate | 4.11 | 4.10 | 0.05 | 18.04 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -3.34% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -12.83 | 4.76 | 4.20 | 4.08 | NA |
Estimate | -11.50 | 4.10 | 4.10 | 3.92 | NA |
Difference | -1.33 | 0.66 | 0.10 | 0.16 | -0.10 |
Surprise | -11.57% | 16.10% | 2.44% | 4.08% | 2.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more